Patents by Inventor Zengmiao Hou

Zengmiao Hou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210121540
    Abstract: The present invention provides novel artificial tears containing a recombinant human lysozyme. The novel artificial tears comprise main components and an auxiliary material. The main components are a recombinant human lysozyme and a sodium hyaluronate, wherein the recombinant human lysozyme and the sodium hyaluronate are contained in an amount from 0.075%-0.300% and from 0.10%-0.30%, respectively in the total mass of the novel artificial tears. A drug for external use is prepared by combining the recombinant human lysozyme, the sodium hyaluronate and an excipient for treating light and moderate dry eye syndrome.
    Type: Application
    Filed: October 1, 2020
    Publication date: April 29, 2021
    Inventors: Jin Shi, Zengmiao Hou, En Gao, Xiaoying Li, Xiaolin Yang, Jinli Zhao
  • Publication number: 20210077384
    Abstract: The present invention provides novel artificial tears containing a recombinant human lysozyme and a recombinant human epidermal growth factor. The novel artificial tears comprise main components and an auxiliary material. The main components are a recombinant human lysozyme, a recombinant human epidermal growth factor, and sodium hyaluronate, wherein the recombinant human lysozyme, the recombinant human epidermal growth factor, and sodium hyaluronate are contained in an amount from 0.075% to 0.300%, from 0.002% to 0.004%, and from 0.10% to 0.30%, respectively in the total mass of the novel artificial tears.
    Type: Application
    Filed: October 1, 2020
    Publication date: March 18, 2021
    Inventors: Jin Shi, Zengmiao Hou, En Gao, Xiaoying Li, Rongrong Pang, Xiaolin Yang, Jinli Zhao
  • Publication number: 20200405610
    Abstract: A cosmetic composition, comprising osteogenic growth peptide carbon-terminal pentapeptide, and at least one of a carrier, a diluent and an adjuvant. The cosmetic composition can promote the proliferation of fibroblasts and the synthesis of skin collagen, and also has the effects of promoting skin wound healing, and eliminating swelling and inflammation.
    Type: Application
    Filed: February 28, 2017
    Publication date: December 31, 2020
    Inventors: Zengmiao Hou, Fei Long, Xiaolin Yang, Jinli Zhao